Abstract
Results for health-related quality of life (HRQoL) from clinical trials are increasingly used for clinical decision making as well as comparative effectiveness, health policy, and reimbursement decisions. Research suggests that HRQoL information can be used to establish treatment preferences because patients value HRQoL data and can interpret HRQoL findings accurately. 1 Brundage M Feldman-Stewart D Leis A et al. Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol. 2005; 23: 6949-6956 Crossref PubMed Scopus (102) Google Scholar Trials that incorporate HRQoL as an outcome should therefore be designed, analysed, and reported well.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
